Biotech

All Articles

Praxis epilepsy medicine minimizes seizures in period 2 hearing

.Praxis Preciseness Medicines has scored another midphase gain in epilepsy this year, with its own s...

Three officers resign as Dyne blog posts mixed information for DMD prospect

.After getting away a scientific grip many years back, Dyne Therapy has uncovered brand new phase 1/...

Arrowhead fires off period 3 records in uncommon metabolic condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its give before a possible face-off along with Ionis, posti...

Pfizer, Valneva reveal lyme ailment shot effective for second enhancer

.Pfizer as well as Valneva may possess about pair of even more years to wait before they help make t...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Let's dive into a chat with Ayla Ellison, Intense Biotech Managing Editor and also Michelle Benz as...

New data show how Bayer's asundexian failed to avoid strokes

.Bayer put on hold the period 3 test for its own factor XIa inhibitor asundexian late in 2015 after ...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its several sclerosis (MS) med tolebrutinib to the FDA, e...

Galapagos' stock up as fund presents intent to shape its evolution

.Galapagos is actually coming under extra tension from entrepreneurs. Having actually built a 9.9% c...

Cell- focused Sana gathers initial CSO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of substantial management hirings, firings as we...

Allist pays off Jacobio $21M, landing task in Mandarin KRAS nationality

.Shanghai Allist Pharmaceuticals has purchased on its own a starring character in China's KRAS marke...